|
rs1801282
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The stratified analysis revealed <i>PPARG</i> rs1801282 C>G polymorphism also had a tendency of decreased risk to colon cancer (CG <i>vs</i>.
|
29246001 |
2017 |
|
rs1801282
|
|
|
0.040 |
GeneticVariation |
BEFREE |
PPAR-gamma 34 C>G is associated with colon cancer risk, but not associated with CRC and rectal cancer risk.
|
20440859 |
2010 |
|
rs1801282
|
|
|
0.040 |
GeneticVariation |
BEFREE |
There was a significant interaction between the -200A>C IGFBP3 polymorphism and the Pro12Ala PPARgamma polymorphism and risk of colon cancer (p for interaction = 0.02) with individuals being at significantly lower risk if they had both the CC IGFBP3 genotype and the PA/AA PPARgamma genotype.
|
16489531 |
2006 |
|
rs1801282
|
|
|
0.040 |
GeneticVariation |
BEFREE |
In this study we evaluated the association between the Pro12Ala (P12A) PPARgamma polymorphism and body mass index (BMI), waist-to-hip ratio (WHR), physical activity level, and energy intake and risk of colorectal cancer using data from a population-based, case-control study of colon cancer (1,577 cases and 1,971 controls) and rectal cancer (794 cases and 1,001 controls).
|
15860437 |
2005 |
|
rs1805192
|
|
|
0.030 |
GeneticVariation |
BEFREE |
PPAR-gamma 34 C>G is associated with colon cancer risk, but not associated with CRC and rectal cancer risk.
|
20440859 |
2010 |
|
rs1805192
|
|
|
0.030 |
GeneticVariation |
BEFREE |
There was a significant interaction between the -200A>C IGFBP3 polymorphism and the Pro12Ala PPARgamma polymorphism and risk of colon cancer (p for interaction = 0.02) with individuals being at significantly lower risk if they had both the CC IGFBP3 genotype and the PA/AA PPARgamma genotype.
|
16489531 |
2006 |
|
rs1805192
|
|
|
0.030 |
GeneticVariation |
BEFREE |
In this study we evaluated the association between the Pro12Ala (P12A) PPARgamma polymorphism and body mass index (BMI), waist-to-hip ratio (WHR), physical activity level, and energy intake and risk of colorectal cancer using data from a population-based, case-control study of colon cancer (1,577 cases and 1,971 controls) and rectal cancer (794 cases and 1,001 controls).
|
15860437 |
2005 |